Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Karim Vermaelen

Work address: C. Heymanslaan 10
9000 Gent
Email: Karim.Vermaelen@UGent.be
ORCID iD: https://orcid.org/0000-0002-6787-8577

Show Sort by

Mark
Perspectives on the integration of immuno-oncology biomarkers and drugs in a health care setting

Karim Vermaelen (UGent) , A Waeytens, O Kholmanskikh, M Van den Bulcke and E Van Valckenborgh

(2018) SEMINARS IN CANCER BIOLOGY. 52. p.166-177
Mark
- journalArticle
- A2
- open access
An unusual presentation of a case of human psittacosis

Yannick Vande Weygaerde (UGent) , Charlot Versteele (UGent) , Elke Thijs, Anton De Spiegeleer (UGent) , Jerina Boelens (UGent) , Daisy Vanrompay (UGent) , Eva Van Braeckel (UGent) and Karim Vermaelen (UGent)

(2018) RESPIRATORY MEDICINE CASE REPORTS. 23. p.138-142
Mark
The role of dicer in alveolar macrophages and dendritic cells in smoke-induced inflammation

Elise De Smet (UGent) , Pieter Mestdagh (UGent) , S Provoost, Leen Seys (UGent) , Guy Joos (UGent) , Karim Vermaelen (UGent) , Guy Brusselle (UGent) and Ken Bracke (UGent)

(2017) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 195.
Mark
Bijwerkingen van 'immune checkpoint' inhibitoren : waar dient een huisarts alert op te zijn?

S De Keukeleire, Tessa Kerre (UGent) , Piet Ost (UGent) , Barbara De Moerloose (UGent) , Karim Vermaelen (UGent) , Lieve Brochez (UGent) and Vibeke Kruse (UGent)

(2017) TIJDSCHRIFT VOOR GENEESKUNDE. 73(18). p.1105-1111
Mark
The ION-Ghent guidelines for the management of immune related adverse events (irAE's)

Vibeke Kruse (UGent) , Max Schreuer (UGent) , Karim Vermaelen (UGent) , Piet Ost (UGent) , Tessa Kerre (UGent) , Barbara De Moerloose (UGent) and Lieve Brochez (UGent)

(2017) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 11(6). p.265-275
Mark
- journalArticle
- A1
- open access
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial

Katrien De Wolf, Sylvie Rottey (UGent) , Karim Vermaelen (UGent) , Karel Decaestecker (UGent) , Nora Sundahl (UGent) , Lizzy De Lobel (UGent) , Els Goetghebeur (UGent) , Gert De Meerleer (UGent) , Nicolaas Lumen (UGent) , Valerie Fonteyne (UGent) , et al.

(2017) RADIATION ONCOLOGY. 12.
Mark
- journalArticle
- A1
- open access
Polyelectrolyte-enrobed cancer cells in view of personalized immune-therapy

Lien Lybaert (UGent) , Keun Ah Ryu, Riet De Rycke (UGent) , Alfred C Chon, Olivier De Wever (UGent) , Karim Vermaelen (UGent) , Aaron Esser-Kahn and Bruno De Geest (UGent)

(2017) ADVANCED SCIENCE. 4(6).
Mark
- journalArticle
- A1
- open access
Biomarkers for early diagnosis of malignant mesothelioma : do we need another moonshot?

Sabrina Lagniau (UGent) , Kevin Lamote (UGent) , Jan Van Meerbeeck (UGent) and Karim Vermaelen (UGent)

(2017) ONCOTARGET. 8(32). p.53751-53762
Mark
- journalArticle
- A1
- open access
The immunophenotypic fingerprint of patients with primary antibody deficiencies is partially present in their asymptomatic first-degree relatives

Delfien Bogaert (UGent) , Marieke De Bruyne (UGent) , Veronique Debacker (UGent) , Pauline Depuydt (UGent) , Katleen De Preter (UGent) , Carolien Bonroy (UGent) , Jan Philippé (UGent) , Maria Bordon Cueto De Braem (UGent) , Bart Lambrecht (UGent) , Tessa Kerre (UGent) , et al.

(2017) HAEMATOLOGICA. 102(1). p.192-202
Mark
- journalArticle
- A1
- open access
The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome

Lotte Pyfferoen (UGent) , Elisabeth Brabants (UGent) , Celine Everaert (UGent) , Nancy De Cabooter (UGent) , Kelly Heyns (UGent) , Kim Deswarte (UGent) , Manon Vanheerswynghels (UGent) , Sofie De Prijck (UGent) , Glenn Waegemans, Melissa Dullaers (UGent) , et al.

(2017) ONCOIMMUNOLOGY. 6(1).

1
2
3
4
…
6
7

Next →